カテゴリ： IMARC, 世界, 医療/バイオ

バイオ医薬品の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

■ 英語タイトル：Biopharmaceutical Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

調査会社IMARC社が発行したリサーチレポート（データ管理コード：IMARC23AL0012）■ 発行会社/調査会社：IMARC
■ 商品コード：IMARC23AL0012
■ 発行日：2023年3月18日
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：178
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール
■ 販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※IMARC社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[バイオ医薬品の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

IMARC社の市場調査資料によると、2022年に2,736億ドルであった世界のバイオ医薬品市場規模が2028年には4,800億ドルまで成長し、予測期間中（2023年～2028年）に年平均10.1％拡大すると予測されています。こちらの資料では、バイオ医薬品の世界市場を総合的に調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、機能別（自己免疫疾患、腫瘍、代謝性疾患、その他）分析、クラス別（組換えタンパク質、モノクローナル抗体、精製タンパク質）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋）分析、SWOT分析、競合状況などを整理しています。並びに、本資料には、AbbVie Inc.、Amgen Inc、Biogen Inc.、Eli Lilly and Company、F. Hoffmann-La Roche AG、Johnson & Johnson、Merck & Co. Inc.、Novo Nordisk A/S、Pfizer Inc.、and Sanofi S.A.などの企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界のバイオ医薬品市場規模：機能別
- 自己免疫疾患における市場規模
- 腫瘍における市場規模
- 代謝性疾患における市場規模
- その他機能における市場規模
・世界のバイオ医薬品市場規模：クラス別
- 組換えタンパク質の市場規模
- モノクローナル抗体の市場規模
- 精製タンパク質の市場規模
・世界のバイオ医薬品市場規模：地域別
- 北米のバイオ医薬品市場規模
- 中南米のバイオ医薬品市場規模
- ヨーロッパのバイオ医薬品市場規模
- アジア太平洋のバイオ医薬品市場規模
・SWOT分析
・競合状況

世界のバイオ医薬品市場規模は2022年に2,736億米ドルに達しました。IMARCグループは、2023年から2028年にかけて10.1%の成長率（CAGR）を示し、2028年までに4,800億米ドルに達すると予測しています。

バイオ医薬品は、ヒト、動物、微生物などの生物学的な供給源から抽出されるか、組換えデオキシリボ核酸（DNA）技術を用いて合成される複合医薬品です。糖、タンパク質、核酸、生きた細胞、組織、そしてさまざまな成分の複雑な組み合わせからなります。これらは、ワクチン、血液成分、体細胞・組織、アレルゲン、細胞療法、遺伝子療法、組換え治療用タンパク質に使用される生きた細胞の製造を助けます。また、がん、糖尿病、心血管疾患、免疫疾患、その他の健康問題の治療にも役立ち、標的を絞った治療と副作用の低減を実現します。

バイオ医薬品市場の動向
免疫血清、ホルモン、サイトカイン、酵素、モノクローナル抗体など、バイオ医薬品の利用が拡大していることは、現在、市場を牽引する重要な要因の一つとなっている。さらに、関節リウマチ、多発性硬化症、心血管疾患を治療するためのモノクローナル抗体の需要が世界中で増加している。これは、タバコやアルコールの過剰摂取、栄養不良、運動不足による慢性疾患の有病率の上昇とともに、市場の成長を促進している。加えて、他の医薬品や医療機器が利用できない様々な疾患を治療するために、細胞や遺伝子をベースとしたバイオ医薬品の利用が増加しており、業界の投資家に有利な成長機会を提供している。これに加えて、主要な市場参入企業は、治療不可能な疾患を治療するための革新的な医薬品を導入するため、研究開発（R&D）活動に幅広く投資している。これは、バイオ医薬品の利点に関する大衆の意識の高まりと相まって、市場にプラスの影響を与えている。これとは別に、急成長するヘルスケア産業とともに、老年人口の増加がバイオ医薬品の需要を刺激している。さらに、がん細胞の増殖と生存に関与する特定の遺伝子やタンパク質を標的とする標的療法に対する需要の高まりが、市場の成長を後押ししている。

主な市場セグメンテーション
IMARC Groupは、2023年から2028年までの世界、地域、国レベルでの予測とともに、世界のバイオ医薬品市場レポートの各サブセグメントにおける主要動向の分析を提供しています。当レポートでは、適応症とクラスに基づいて市場を分類しています。

適応症別内訳
自己免疫疾患
腫瘍学
代謝疾患
その他

自己免疫疾患は、環境暴露の増大と個人の食習慣の変化により、現在市場を支配しています。

クラス別内訳
組み換えタンパク質
モノクローナル抗体
精製タンパク質

現在、モノクローナル抗体が最大の市場シェアを占めています。その理由は、治療用途が拡大していることと、単一のエピトープに対する特異性が高く交差反応性が低いためです。

地域別内訳
北米
米国
カナダ
ラテンアメリカ
メキシコ
ブラジル
アルゼンチン
ヨーロッパ
ドイツ
フランス
イタリア
スペイン
イギリス
ロシア
トルコ
アジア太平洋
日本
中国
オーストラリア
韓国
インド
インドネシア

現在、世界最大のバイオ医薬品市場は北米です。さらに米国とカナダに区分されます。

本レポートで扱う主な質問
1. 2022年の世界のバイオ医薬品市場規模は？
2. 2023-2028年の世界のバイオ医薬品市場の成長率は？
3. バイオ医薬品の世界市場を牽引する主要因は何か？
4. COVID-19が世界のバイオ医薬品市場に与えた影響は？
5. 世界のバイオ医薬品市場の適応症別内訳は？
6. バイオ医薬品世界市場のクラス別内訳は？
7. バイオ医薬品の世界市場における主要地域は？
8. バイオ医薬品の世界市場における主要プレイヤー/企業は？

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
5 Global Biopharmaceutical Market
5.1 Market Performance and Forecast
5.1.1 Current Performance (2017-2022)
5.1.2 Market Forecast (2023-2028)
5.2 Impact of COVID-19
5.3 Market by Region
5.3.1 Current Performance (2017-2022)
5.3.2 Market Forecast (2023-2028)
5.4 Market by Indication
5.4.1 Autoimmune Diseases
5.4.2 Oncology
5.4.3 Metabolic Disorders
5.4.4 Others
5.5 Market by Class
5.5.1 Recombinant Proteins
5.5.1.1 Current Performance (2017-2022)
5.5.1.2 Market Forecast (2023-2028)
5.5.2 Monoclonal Antibodies
5.5.2.1 Current Performance (2017-2022)
5.5.2.2 Market Forecast (2023-2028)
5.5.3 Purified Proteins
5.5.3.1 Current Performance (2017-2022)
5.5.3.2 Market Forecast (2023-2028)
5.6 Competitive Landscape
5.6.1 Top Biopharmaceutical Players
5.6.2 Top Biopharmaceutical Drugs
5.7 Value Chain Analysis
5.8 Porter’s Five Forces Analysis
5.8.1 Overview
5.8.2 Bargaining Power of Buyers
5.8.3 Bargaining Power of Suppliers
5.8.4 Degree of Rivalry
5.8.5 Threat of New Entrants
5.8.6 Threat of Substitutes
6 North America
6.1 United States
6.1.1 Market Performance (2017-2022)
6.1.2 Market by Class
6.1.2.1 Recombinant Proteins
6.1.2.2 Monoclonal Antibodies
6.1.2.3 Purified Proteins
6.1.3 Top Players
6.1.4 Market Forecast (2023-2028)
6.2 Canada
6.2.1 Market Performance (2017-2022)
6.2.2 Market by Class
6.2.2.1 Recombinant Proteins
6.2.2.2 Monoclonal Antibodies
6.2.2.3 Purified Proteins
6.2.3 Top Players
6.2.4 Market Forecast (2023-2028)
7 Latin America
7.1 Mexico
7.1.1 Market Performance (2017-2022)
7.1.2 Market by Class
7.1.2.1 Recombinant Proteins
7.1.2.2 Monoclonal Antibodies
7.1.2.3 Purified Proteins
7.1.3 Top Players
7.1.4 Market Forecast (2023-2028)
7.2 Brazil
7.2.1 Market Performance (2017-2022)
7.2.2 Market by Class
7.2.2.1 Recombinant Proteins
7.2.2.2 Monoclonal Antibodies
7.2.2.3 Purified Proteins
7.2.3 Top Players
7.2.4 Market Forecast (2023-2028)
7.3 Argentina
7.3.1 Market Performance (2017-2022)
7.3.2 Market by Class
7.3.2.1 Recombinant Proteins
7.3.2.2 Monoclonal Antibodies
7.3.2.3 Purified Proteins
7.3.3 Top Players
7.3.4 Market Forecast (2023-2028)
8 Europe
8.1 Germany
8.1.1 Market Performance (2017-2022)
8.1.2 Market by Class
8.1.2.1 Recombinant Proteins
8.1.2.2 Monoclonal Antibodies
8.1.2.3 Purified Proteins
8.1.3 Top Players
8.1.4 Market Forecast (2023-2028)
8.2 France
8.2.1 Market Performance (2017-2022)
8.2.2 Market by Class
8.2.2.1 Recombinant Proteins
8.2.2.2 Monoclonal Antibodies
8.2.2.3 Purified Proteins
8.2.3 Top Players
8.2.4 Market Forecast (2023-2028)
8.3 Italy
8.3.1 Market Performance (2017-2022)
8.3.2 Market by Class
8.3.2.1 Recombinant Proteins
8.3.2.2 Monoclonal Antibodies
8.3.2.3 Purified Proteins
8.3.3 Top Players
8.3.4 Market Forecast (2023-2028)
8.4 Spain
8.4.1 Market Performance (2017-2022)
8.4.2 Market by Class
8.4.2.1 Recombinant Proteins
8.4.2.2 Monoclonal Antibodies
8.4.2.3 Purified Proteins
8.4.3 Top Players
8.4.4 Market Forecast (2023-2028)
8.5 United Kingdom
8.5.1 Market Performance (2017-2022)
8.5.2 Market by Class
8.5.2.1 Recombinant Proteins
8.5.2.2 Monoclonal Antibodies
8.5.2.3 Purified Proteins
8.5.3 Top Players
8.5.4 Market Forecast (2023-2028)
8.6 Russia
8.6.1 Market Performance (2017-2022)
8.6.2 Market by Class
8.6.2.1 Recombinant Proteins
8.6.2.2 Monoclonal Antibodies
8.6.2.3 Purified Proteins
8.6.3 Top Players
8.6.4 Market Forecast (2023-2028)
8.7 Turkey
8.7.1 Market Performance (2017-2022)
8.7.2 Market by Class
8.7.2.1 Recombinant Proteins
8.7.2.2 Monoclonal Antibodies
8.7.2.3 Purified Proteins
8.7.3 Top Players
8.7.4 Market Forecast (2023-2028)
9 Asia Pacific
9.1 Japan
9.1.1 Market Performance (2017-2022)
9.1.2 Market by Class
9.1.2.1 Recombinant Proteins
9.1.2.2 Monoclonal Antibodies
9.1.2.3 Purified Proteins
9.1.3 Top Players
9.1.4 Market Forecast (2023-2028)
9.2 China
9.2.1 Market Performance (2017-2022)
9.2.2 Market by Class
9.2.2.1 Recombinant Proteins
9.2.2.2 Monoclonal Antibodies
9.2.2.3 Purified Proteins
9.2.3 Top Players
9.2.4 Market Forecast (2023-2028)
9.3 Australia
9.3.1 Market Performance (2017-2022)
9.3.2 Market by Class
9.3.2.1 Recombinant Proteins
9.3.2.2 Monoclonal Antibodies
9.3.2.3 Purified Proteins
9.3.3 Top Players
9.3.4 Market Forecast (2023-2028)
9.4 South Korea
9.4.1 Market Performance (2017-2022)
9.4.1.1 Recombinant Proteins
9.4.1.2 Monoclonal Antibodies
9.4.1.3 Purified Proteins
9.4.2 Top Players
9.4.3 Market Forecast (2023-2028)
9.5 India
9.5.1 Market Performance (2017-2022)
9.5.2 Market by Class
9.5.2.1 Recombinant Proteins
9.5.2.2 Monoclonal Antibodies
9.5.2.3 Purified Proteins
9.5.3 Top Players
9.5.4 Market Forecast (2023-2028)
9.6 Indonesia
9.6.1 Market Performance (2017-2022)
9.6.2 Market by Class
9.6.2.1 Recombinant Proteins
9.6.2.2 Monoclonal Antibodies
9.6.2.3 Purified Proteins
9.6.3 Top Players
9.6.4 Market Forecast (2023-2028)
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players
11.3 Profiles of Key Players
11.3.1 AbbVie Inc.
11.3.2 Amgen Inc
11.3.3 Biogen Inc.
11.3.4 Eli Lilly and Company
11.3.5 F. Hoffmann-La Roche AG
11.3.6 Johnson & Johnson
11.3.7 Merck & Co. Inc.
11.3.8 Novo Nordisk A/S
11.3.9 Pfizer Inc.
11.3.10 Sanofi S.A

Figure 1: Global: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 2: Complexity of Biopharmaceuticals
Figure 3: Sources of Biopharmaceuticals
Figure 4: Global: Biopharmaceutical Market: Value Trends (in Billion US$), 2017-2022
Figure 5: Global: Biopharmaceutical Market Forecast: Value Trends (in Billion US$), 2023-2028
Figure 6: Global: Biopharmaceutical Market: Sales Share by Country (in %), 2022
Figure 7: Global: Biopharmaceutical Market Forecast: Sales Share by Country (in %), 2028
Figure 8: Global: Biopharmaceutical Market: Sales Share by Indication (in %), 2022
Figure 9: Global: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 10: Global: Biopharmaceutical Market Forecast: Sales by Class (in Million US$), 2023-2028
Figure 11: Global: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 12: Global: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 13: Global: Recombinant Proteins Market Forecast (in Million US$), 2023-2028
Figure 14: Global: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 15: Global: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 16: Global: Monoclonal Antibodies Market Forecast (in Million US$), 2023-2028
Figure 17: Global: Purified Proteins Market (in Million US$), 2017-2022
Figure 18: Global: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 19: Global: Purified Proteins Market Forecast (in Million US$), 2023-2028
Figure 20: Global: Biopharmaceutical Market: Sales Share of Top Biopharmaceuticals (in %)
Figure 21: Global: Biopharmaceutical Industry: Value Chain Analysis
Figure 22: Global: Biopharmaceutical Industry: Porter’s Five Forces Analysis
Figure 23: United States: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 24: United States: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 25: United States: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 26: United States: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 27: United States: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 28: United States: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 29: United States: Purified Proteins Market (in Million US$), 2017-2022
Figure 30: United States: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 31: United States: Biopharmaceutical Market: Sales Share of Top Players (in %), 2022
Figure 32: United States: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 33: United States: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 34: Canada: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 35: Canada: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 36: Canada: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 37: Canada: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 38: Canada: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 39: Canada: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 40: Canada: Biopharmaceutical Market: Sales Share of Top Players (in %), 2022
Figure 41: Canada: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 42: Canada: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 43: Mexico: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 44: Mexico: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 45: Mexico: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 46: Mexico: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 47: Mexico: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 48: Mexico: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 49: Mexico: Purified Proteins Market (in '000 US$), 2017-2022
Figure 50: Mexico: Biopharmaceutical Market: Sales Share of Top Players (in %), 2022
Figure 51: Mexico: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 52: Mexico: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 53: Brazil: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 54: Brazil: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 55: Brazil: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 56: Brazil: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 57: Brazil: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 58: Brazil: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 59: Brazil: Purified Proteins Market (in Million US$), 2017-2022
Figure 60: Brazil: Biopharmaceutical Market: Sales Share of Top Players (in %), 2022
Figure 61: Brazil: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 62: Brazil: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 63: Argentina: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 64: Argentina: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 65: Argentina: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 66: Argentina: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 67: Argentina: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 68: Argentina: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 69: Argentina: Purified Proteins Market (in Million US$), 2017-2022
Figure 70: Argentina: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 71: Argentina: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 72: Argentina: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 73: Germany: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 74: Germany: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 75: Germany: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 76: Germany: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 77: Germany: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 78: Germany: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 79: Germany: Purified Proteins Market (in Million US$), 2017-2022
Figure 80: Germany: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 81: Germany: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 82: Germany: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 83: Germany: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 84: France: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 85: France: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 86: France: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 87: France: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 88: France: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 89: France: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 90: France: Purified Proteins Market (in Million US$), 2017-2022
Figure 91: France: Biopharmaceutical Market: Sales Share of Top Players (in %), 2022
Figure 92: France: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 93: France: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 94: Italy: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 95: Italy: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 96: Italy: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 97: Italy: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 98: Italy: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 99: Italy: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 100: Italy: Purified Proteins Market (in Million US$), 2017-2022
Figure 101: Italy: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 102: Italy: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 103: Italy: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 104: Spain: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 105: Spain: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 106: Spain: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 107: Spain: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 108: Spain: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 109: Spain: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 110: Spain: Purified Proteins Market (in Million US$), 2017-2022
Figure 111: Spain: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 112: Spain: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 113: Spain: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 114: Spain: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 115: UK: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 116: UK: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 117: UK: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 118: UK: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 119: UK: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 120: UK: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 121: UK: Purified Proteins Market (in Million US$), 2017-2022
Figure 122: UK: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 123: UK: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 124: UK: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 125: UK: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 126: Russia: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 127: Russia: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 128: Russia: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 129: Russia: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 130: Russia: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 131: Russia: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 132: Russia: Purified Proteins Market: (in Million US$), 2017-2022
Figure 133: Russia: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 134: Russia: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 135: Russia: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 136: Russia: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 137: Turkey: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 138: Turkey: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 139: Turkey: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 140: Turkey: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 141: Turkey: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 142: Turkey: Purified Proteins Market (in Million US$), 2017-2022
Figure 143: Turkey: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 144: Turkey: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 145: Turkey: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 146: Japan: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 147: Japan: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 148: Japan: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 149: Japan: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 150: Japan: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 151: Japan: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 152: Japan: Purified Proteins Market (in Million US$), 2017-2022
Figure 153: Japan: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 154: Japan: Biopharmaceutical Market Forecast: Value trend (in Million US$), 2023-2028
Figure 155: Japan: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 156: China: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 157: China: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 158: China: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 159: China: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 160: China: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 161: China: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 162: China: Purified Proteins Market: (in Million US$), 2017-2022
Figure 163: China: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 164: China: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 165: China: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 166: China: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 167: Australia: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 168: Australia: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 169: Australia: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 170: Australia: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 171: Australia: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 172: Australia: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 173: Australia: Purified Proteins Market (in Million US$), 2017-2022
Figure 174: Australia: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 175: Australia: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 176: Australia: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 177: South Korea: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 178: South Korea: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 179: South Korea: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 180: South Korea: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 181: South Korea: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 182: South Korea: Monoclonal Antibodies Market: Sales Share by Class, (in %), 2022
Figure 183: South Korea: Purified Proteins Market (in Million US$), 2017-2022
Figure 184: South Korea: Purified Proteins Market: Sales Share by Class (in %), 2022
Figure 185: South Korea: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 186: South Korea: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 187: South Korea: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 188: India: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 189: India: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 190: India: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 191: India: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 192: India: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 193: India: Purified Proteins Market (in Million US$), 2017-2022
Figure 194: India: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 195: India: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 196: India: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 197: Indonesia: Biopharmaceutical Market (in Million US$), 2017-2022
Figure 198: Indonesia: Biopharmaceutical Market: Sales by Class (in Million US$), 2017-2022
Figure 199: Indonesia: Recombinant Proteins Market (in Million US$), 2017-2022
Figure 200: Indonesia: Recombinant Proteins Market: Sales Share by Class (in %), 2022
Figure 201: Indonesia: Monoclonal Antibodies Market (in Million US$), 2017-2022
Figure 202: Indonesia: Monoclonal Antibodies Market: Sales Share by Class (in %), 2022
Figure 203: Indonesia: Biopharmaceutical Market: Sales Share of Top Players (in %)
Figure 204: Indonesia: Biopharmaceutical Market Forecast (in Million US$), 2023-2028
Figure 205: Indonesia: Biopharmaceutical Market Forecast: Sales Share by Class (in %), 2028
Figure 206: Global: Share of Biopharmaceuticals & Small Molecule Drugs Among the Top Ten Selling Drugs (in %), 2001 & 2022
Figure 207: Using a Different Manufacturing Process Makes it Extremely Difficult for Biosimilars to be Equivalent to Originator Products
Figure 208: Marked Differences Between Biosimilar and Branded Biopharmaceuticals When a Different Production Process was Used
Figure 209: Transition Probabilities of Biopharmaceuticals & Small Molecule Drugs in Clinical Phases, (in %)
Figure 210: Comparison of the Average Annual Cost of Therapy Using Biopharmaceuticals and Small Molecule Drugs (in US$)
Figure 211: Emerging Biopharmaceutical Market Forecast (in Million US$), 2022 & 2028
Figure 212: Developed Biopharmaceutical Market Forecast (in Million US$), 2022 & 2028
Figure 213: Breakup of Biopharmaceuticals and Small Molecule Drugs Receiving FDA Approval (in Numbers), 2002-2022
Figure 214: A Comparison of the Costs Incurred While Developing Biopharmaceuticals and Small Molecule Drugs (in Million US$)
Figure 215: Comparison of the Research & Development Times for Biopharmaceuticals & Small Molecule Drugs (in Months)

Table 1: Global: Biopharmaceutical Market: Definition & Segmentation
Table 2: Global: Biopharmaceutical Market: SWOT Analysis
Table 3: Global: Biopharmaceutical Market Forecast: Sales by Region (in Million US$), 2022 & 2028
Table 4: Differences Between Small Molecule Drugs & Biopharmaceuticals
Table 5: Complexity of Manufacturing Process Involved with Biopharmaceuticals & Small Molecule Drugs
Table 6: Global: Biopharmaceutical Market: Sales by Country (in Million US$), 2017-2022
Table 7: Global: Biopharmaceutical Market Forecast: Sales by Country (in Million US$), 2023-2028
Table 8: Global: Biopharmaceutical Market: Sales by Indication (in Billion US$), 2022
Table 9: Mode of Administration of Popular Biotech Drugs


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 使い捨てバイオリアクターの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 生物製剤のグローバル市場：産業動向、シェア、規模、成長、機会・予測（2023～2028）
  • がんモノクローナル抗体の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 医薬品有効成分（API）の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IMARC23AL0012 )"バイオ医薬品の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測" (英文：Biopharmaceutical Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)はIMARC社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。